期刊
JOURNAL OF ECONOMIC LITERATURE
卷 56, 期 2, 页码 397-449出版社
AMER ECONOMIC ASSOC
DOI: 10.1257/jel.20161327
关键词
-
类别
资金
- National Institute on Aging [P01 AG033559]
The pharmaceutical industry accounts for a substantial chunk of the US economy's research and development investments, which have resulted in significant medical breakthroughs. At the same time, the costs of pharmaceutical products continue to rise, as does pressure to adopt direct or indirect controls on pharmaceutical prices. We review the economics literature on the pharmaceutical industry, focusing particularly on its positive and normative implications for the innovation, pricing, and marketing decisions of pharmaceutical firms. We discuss the major achievements of, and persistent gaps in, the literature, along with lessons for policy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据